Columbus Macro LLC Increases Stock Holdings in Kenvue Inc. $KVUE

Key Points

• Columbus Macro LLC increased its stock holdings in Kenvue Inc. by 10.2%, now owning 314,206 shares valued at approximately $6.58 million as of the end of the most recent quarter.
• Kenvue's latest quarterly earnings showed a beating of EPS estimates at $0.29, despite revenue of $3.84 billion falling short of expectations.
• The company recently raised its quarterly dividend to $0.2075 per share, translating to an annualized yield of 5.2%.

Columbus Macro LLC grew its position in Kenvue Inc. (NYSE:KVUE - Free Report) by 10.2% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 314,206 shares of the company's stock after buying an additional 29,137 shares during the quarter. Columbus Macro LLC's holdings in Kenvue were worth $6,576,000 at the end of the most recent quarter.

A number of other hedge funds have also made changes to their positions in the company. Maryland State Retirement & Pension System increased its position in Kenvue by 3.2% during the 2nd quarter. Maryland State Retirement & Pension System now owns 92,360 shares of the company's stock worth $1,933,000 after purchasing an additional 2,841 shares in the last quarter. WESPAC Advisors LLC purchased a new stake in Kenvue during the 2nd quarter worth about $544,000. Proffitt & Goodson Inc. increased its position in Kenvue by 8.2% during the 2nd quarter. Proffitt & Goodson Inc. now owns 6,831 shares of the company's stock worth $143,000 after purchasing an additional 517 shares in the last quarter. KLP Kapitalforvaltning AS increased its position in Kenvue by 21.3% during the 2nd quarter. KLP Kapitalforvaltning AS now owns 1,072,646 shares of the company's stock worth $22,450,000 after purchasing an additional 188,100 shares in the last quarter. Finally, Valeo Financial Advisors LLC increased its position in Kenvue by 7.6% during the 2nd quarter. Valeo Financial Advisors LLC now owns 15,868 shares of the company's stock worth $332,000 after purchasing an additional 1,127 shares in the last quarter. Hedge funds and other institutional investors own 97.64% of the company's stock.

Wall Street Analyst Weigh In

A number of analysts recently commented on KVUE shares. Rothschild Redb upgraded Kenvue from a "hold" rating to a "strong-buy" rating in a research report on Friday, September 26th. Barclays dropped their price objective on Kenvue from $20.00 to $17.00 and set an "equal weight" rating for the company in a research report on Wednesday, October 1st. Redburn Partners set a $22.00 price objective on Kenvue in a research report on Friday, September 26th. Citigroup reissued a "neutral" rating on shares of Kenvue in a research note on Tuesday, September 23rd. Finally, Rothschild & Co Redburn raised Kenvue from a "neutral" rating to a "buy" rating and decreased their price target for the stock from $22.50 to $22.00 in a research note on Friday, September 26th. One analyst has rated the stock with a Strong Buy rating, five have given a Buy rating, nine have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the company presently has a consensus rating of "Hold" and an average price target of $21.75.

Kenvue Stock Down 0.9%

Shares of NYSE:KVUE opened at $16.08 on Thursday. The stock's 50-day moving average price is $19.34 and its two-hundred day moving average price is $21.43. The company has a current ratio of 0.98, a quick ratio of 0.68 and a debt-to-equity ratio of 0.66. Kenvue Inc. has a 12-month low of $15.47 and a 12-month high of $25.17. The firm has a market cap of $30.86 billion, a price-to-earnings ratio of 21.73, a PEG ratio of 2.33 and a beta of 0.72.

Kenvue (NYSE:KVUE - Get Free Report) last released its quarterly earnings data on Thursday, August 7th. The company reported $0.29 earnings per share for the quarter, beating the consensus estimate of $0.28 by $0.01. The business had revenue of $3.84 billion for the quarter, compared to analyst estimates of $3.94 billion. Kenvue had a return on equity of 20.06% and a net margin of 9.37%.The company's revenue was down 4.0% compared to the same quarter last year. During the same period in the previous year, the company posted $0.32 EPS. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. On average, research analysts forecast that Kenvue Inc. will post 1.14 EPS for the current year.

Kenvue Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, August 27th. Stockholders of record on Wednesday, August 13th were paid a $0.2075 dividend. The ex-dividend date of this dividend was Wednesday, August 13th. This represents a $0.83 annualized dividend and a dividend yield of 5.2%. This is an increase from Kenvue's previous quarterly dividend of $0.21. Kenvue's dividend payout ratio is presently 112.16%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.